CN1206612A - Anti-cancer health care tea and preparation process thereof - Google Patents

Anti-cancer health care tea and preparation process thereof Download PDF

Info

Publication number
CN1206612A
CN1206612A CN 98111411 CN98111411A CN1206612A CN 1206612 A CN1206612 A CN 1206612A CN 98111411 CN98111411 CN 98111411 CN 98111411 A CN98111411 A CN 98111411A CN 1206612 A CN1206612 A CN 1206612A
Authority
CN
China
Prior art keywords
radix
tea
fructus
folium camelliae
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 98111411
Other languages
Chinese (zh)
Inventor
向加凌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 98111411 priority Critical patent/CN1206612A/en
Publication of CN1206612A publication Critical patent/CN1206612A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a kind of anticancer health care tea, it is made up by mixing tea and medicinal components. The medicinal components consist of pilose asiabell, root of membranous milk vetch, prepared rhizome of rehmannia, rhizome of large-headed atractylodes, psoralea fruit, fruit of glossy privet, tuber of multiflower knotweed, Chinese angelica etc. 16 traditional Chinese medicinal herbs. Said health care tea mixes organically various components together and features strong, convenient, effective, cheap and there is no toxic side effect. A long term administration of said tea can enhance the immuocompetence and possess of the preventative effect for various cancers.

Description

Anticancer health-protecting tea and technology
The present invention relates to a kind of preparation, especially a kind of preparation with tea of anticancer health-care effect with medical value tea.The invention still further relates to the process for making of this tea.
Along with the development of continuous progress, the especially medical and health care system of science, human average life significant prolongation.But the M ﹠ M of cancer but increases rapidly, becomes one of the most serious disease of prestige association's human health and life.Therefore, the control of cancer has been the cardinal task of pendulum in face of modern science worker, particularly medical worker.In recent years, China's medical circle is constantly excavated the precious legacy of motherland's medical science aspect anti-curing cancers, and the monograph of relevant anti-curing cancers comes out successively.Put down in writing plurality of Chinese in these works respectively to certain or contents such as the pharmacology of certain class cancer, prescription on probation.For example put down in writing the curative effect of Radix Bupleuri in " day disclosure special permission communique " (No. 6045521) to lymphatic cancer, " Chinese tumor magazine " (1,987 three phase) put down in writing the curative effect of Fructus Ligustri Lucidi to carninomatosis such as lymph, digestive tract, " Journal of Traditional Chinese Medicine " (1983 third phase) put down in writing the curative effect of the Radix Astragali to pulmonary carcinoma, osteocarcinoma, " combination of Chinese and Western medicine oncology " (1989) have put down in writing the curative effect of Folium Camelliae sinensis to central nervous system's carninomatosis, or the like.The inventor thinks, there is the tendency of " heavily controlling light anti-" in China to cancer at present, so in case manage to treat after cancer takes place, Chinese medicine and western medicine often difficulty has the power capable of saving a desperate situation again.Therefore, cancer being necessary to employ prevention is main strategy.Actively development and the effective cancer therapy drug of penetration and promotion are instant major issues.
Application number is that 93103956.8 Chinese patent " natural health-care tea for prolonging life and preventing cancer " is though disclose a kind of health-care tea with anticancer made from Germinatus Phragmitis, Radix Dauci Sativae, mood ear fungus, green tea, Herb Gynostemmae Pentaphylli, Bulbus Allii, its composition and relevant data show that this tea is difficult to that various common cancers are all had preventive effect.
The objective of the invention is to: propose a kind ofly to have no side effect, have comprehensive anti-cancer effect, and the anticancer health-protecting tea that tea liquid is limpid, mouthfeel is aromatic.Also will provide the process for making of this tea simultaneously.
Anticancer health-protecting tea of the present invention is made up of Folium Camelliae sinensis and drug effect component, and the drug effect component is Radix Codonopsis, the Radix Astragali, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, Fructus Psoraleae, Fructus Ligustri Lucidi, the Radix Polygoni Multiflori, Radix Angelicae Sinensis, Fructus Mume, Radix Bupleuri, Lentinus Edodes, Radix Isatidis, Herba Artemisiae Annuae, beans, Radix Glycyrrhizae, Flos Lonicerae.
The processing technology of anticancer health-protecting tea is:
A. draw materials---choose various drug effect components except that Folium Camelliae sinensis by proportioning Radix Codonopsis 2-5%, Radix Astragali 2-5%, Radix Rehmanniae Preparata 2-5%, Rhizoma Atractylodis Macrocephalae 1-4%, Fructus Psoraleae 1-4%, Fructus Ligustri Lucidi 2-5%, Radix Polygoni Multiflori 2-5%, Radix Angelicae Sinensis 2-5%, Fructus Mume 1-3%, Radix Bupleuri 1-3%, Lentinus Edodes 1-3%, Radix Isatidis 1-3%, Herba Artemisiae Annuae 1-3%, class 2-8%, Radix Glycyrrhizae 0.5-1.5%, Flos Lonicerae 0.5-1.5%, remove wherein impurity;
B. sterilization---use irradiation under ultraviolet ray 30-60 minute, sterilizing;
C. make decoction pieces---will except that Folium Camelliae sinensis, various component cuttings make decoction pieces;
D. mixing---uniform mixing is made the various components of decoction pieces;
E. pulverize---mixed each component is pulverized, and fineness of powder is the 140-200 order;
F. make---in the compound after pulverizing,, make the anticancer health-protecting tea that does not contain any additives in the ratio adding Folium Camelliae sinensis of 40-60%.
Above scheme is selected from the anticancer folk prescription of 600 pleasant impressions and is sifted out by to having the research for many years of anticancer achievement now.The mechanism of action of its cancer preventing health have following some: (1) directly suppresses various common cancerous cell effects---every kind of composition that anticancer health-protecting tea includes all has the effect that suppresses certain or certain quasi-cancer cell.After by the present invention program its reasonable compatibility being mixed, replenish mutually, can strengthen the effect that suppresses various cancerous cell, reach the purpose of anti-cancer, anticancer, life lengthening.(2) regulate body's immunity effect---human immunity comprises cellular immunization and humoral immunization, the former mainly works by leukocyte, mononuclear phagocyte and T cell; After the latter refers to that bone-marrow-derived lymphocyte is accepted antigenic stimulus in the body, the immunization that produces antibody.Radix Codonopsis among the present invention program, Fructus Psoraleae etc. have the drug effect that the body leukocyte is obviously increased; The Radix Astragali can make pulmonary's macrophage amount increase, and strengthens the huge cytophilic metabolism of pulmonary, improves phagocytic index; Fructus Ligustri Lucidi, the Radix Polygoni Multiflori etc. can make lymphocytic conversion ratio greatly improve.Therefore the present invention has the effect that promotes that internal antibody produces, regulates immunity of organisms.(3) antitoxic action---modern medicine proves that the generation of cancers such as nasopharynx, cervix uteri, penis is closely related with virus.Therefore, many antiviral drugs also have positive role to cancer-resisting.Radix Bupleuri among the present invention program has inhibitory action to hepatitis B virus; Radix Isatidis has inhibitory action to Respirovirus; Flos Lonicerae has resistant function to enterovirus.Therefore, the present invention has the effect of inhibition, the multiple virus of opposing.(4) effect of inducement interferon---interferon is present PTS, and compositions more of the present invention have the effect of inducement interferon.For example, Radix Isatidis just has people's umbilical blood LeIF and significantly induces effect.
Anticancer health-protecting tea of the present invention make above-mentioned effect organic fused together, thereby reach the purpose of the various cancers of comprehensive prevention.Selected various natural medicine is good and cheap, effective anticancer folk prescription, has no side effect, and its flavor or sweet or hot or sour or little hardship through repetition test, are made into the present invention program's ratio and technology.Through the anticancer health-protecting tea that is developed into, have by force, just, test, characteristics such as honest and clean, have no side effect, long-term drink can life enhancement, strengthens immune function of human body, have the effect of comprehensive prevention cancer, and mouthfeel is aromatic pleasant.
The invention will be further described below in conjunction with embodiment.
Embodiment
A. press following part by weight selection: Radix Codonopsis 8g (4%), Radix Astragali 8g (4%), Radix Rehmanniae Preparata 8g (4%), Rhizoma Atractylodis Macrocephalae 6g (3%), Fructus Psoraleae 6g (3%), Fructus Ligustri Lucidi 8g (4%), Radix Polygoni Multiflori 8g (4%), Radix Angelicae Sinensis 8g (4%), Fructus Mume 4g (2%), Radix Bupleuri 5g (2.5%), Lentinus Edodes 5g (2.5%), Radix Isatidis 5g (2.5%), Herba Artemisiae Annuae 5g (2.5%), Semen sojae atricolor 6g (3%), Semen phaseoli radiati 6g (3%), Radix Glycyrrhizae 2g (1%), Flos Lonicerae 2g (1%);
B. sterilization---use irradiation under ultraviolet ray 45 minutes, sterilizing;
C. make decoction pieces---will except that Folium Camelliae sinensis, various component cuttings make decoction pieces;
D. mixing---uniform mixing is made the various components of decoction pieces;
E. pulverize---mixed each component is pulverized, and fineness of powder is the 160-180 order;
F. make---in the compound after pulverizing, add 100g (50%) green tea, make the anticancer health-protecting tea that does not contain any additives.
G. pack---the anticancer health-protecting tea of making is packaged in the instant bag.
The proportioning of present embodiment is the desired proportions of determining through repetition test.Because according to the medicine principle of four gas, the five tastes and the choose reasonable of monarch, and adopted green tea, Semen phaseoli radiati, so tea liquid outward appearance is limpid, mouthfeel is aromatic, brain healthy.
Except above embodiment, the present invention also has other embodiment.For example, Folium Camelliae sinensis adopts black tea, scented tea, or the like, these all drop in protection scope of the present invention.

Claims (4)

1. anticancer health-protecting tea, form by Folium Camelliae sinensis and drug effect component, the drug effect component contains Lentinus Edodes, it is characterized in that: described drug effect component also contains Radix Codonopsis, the Radix Astragali, Radix Rehmanniae Preparata, the Rhizoma Atractylodis Macrocephalae, Fructus Psoraleae, Fructus Ligustri Lucidi, the Radix Polygoni Multiflori, Radix Angelicae Sinensis, Fructus Mume, Radix Bupleuri, Radix Isatidis, Herba Artemisiae Annuae, beans, Radix Glycyrrhizae, Flos Lonicerae.
2. according to the processing technology of the described anticancer health-protecting tea of claim 1:
A. draw materials---choose various drug effect components except that Folium Camelliae sinensis by proportioning Radix Codonopsis 2-5%, Radix Astragali 2-5%, Radix Rehmanniae Preparata 2-5%, Rhizoma Atractylodis Macrocephalae 1-4%, Fructus Psoraleae 1-4%, Fructus Ligustri Lucidi 2-5%, Radix Polygoni Multiflori 2-5%, Radix Angelicae Sinensis 2-5%, Fructus Mume 1-3%, Radix Bupleuri 1-3%, mood ear fungus 1-3%, Radix Isatidis 1-3%, Herba Artemisiae Annuae 1-3%, class 2-8%, Radix Glycyrrhizae 0.5-1.5%, Flos Lonicerae 0.5-1.5%, remove wherein impurity;
B. sterilization---use irradiation under ultraviolet ray 30-60 minute, sterilizing;
C. make decoction pieces---will except that Folium Camelliae sinensis, various component cuttings make decoction pieces;
D. mixing---uniform mixing is made the various components of decoction pieces;
E. pulverize---mixed each component is pulverized, and fineness of powder is/the 40-200 order;
F. make---in the compound after pulverizing,, make anticancer health-protecting tea in the ratio adding Folium Camelliae sinensis of 40-60%.
3. anticancer health-protecting tea according to claim 1 is characterized in that: described beans is Semen sojae atricolor and Semen phaseoli radiati.
4. anticancer health-protecting tea according to claim 3 is characterized in that: the proportioning of described efficacy component is: Radix Codonopsis-4%, the Radix Astragali-4%, Radix Rehmanniae Preparata-4%, the Rhizoma Atractylodis Macrocephalae-3%, Fructus Psoraleae-3%, Fructus Ligustri Lucidi-4%, the Radix Polygoni Multiflori-4%, Radix Angelicae Sinensis-4%, Fructus Mume-2%, Radix Bupleuri-2.5%, Lentinus Edodes-2.5%, Radix Isatidis-2.5%, Herba Artemisiae Annuae-2.5%, Semen sojae atricolor-3%, Semen phaseoli radiati-3%, Radix Glycyrrhizae-1%, Flos Lonicerae-1%.
CN 98111411 1998-07-15 1998-07-15 Anti-cancer health care tea and preparation process thereof Pending CN1206612A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 98111411 CN1206612A (en) 1998-07-15 1998-07-15 Anti-cancer health care tea and preparation process thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 98111411 CN1206612A (en) 1998-07-15 1998-07-15 Anti-cancer health care tea and preparation process thereof

Publications (1)

Publication Number Publication Date
CN1206612A true CN1206612A (en) 1999-02-03

Family

ID=5221393

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 98111411 Pending CN1206612A (en) 1998-07-15 1998-07-15 Anti-cancer health care tea and preparation process thereof

Country Status (1)

Country Link
CN (1) CN1206612A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100364434C (en) * 2005-12-01 2008-01-30 肖伟民 Health-caring tea of sweet wormwood and its preparation
CN1943379B (en) * 2006-10-21 2010-05-12 蒋火金 Honeysuckle bagged tea and its preparing method
CN113197969A (en) * 2021-05-31 2021-08-03 北京洪山医药科技有限公司 Tumor inhibition preparation and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100364434C (en) * 2005-12-01 2008-01-30 肖伟民 Health-caring tea of sweet wormwood and its preparation
CN1943379B (en) * 2006-10-21 2010-05-12 蒋火金 Honeysuckle bagged tea and its preparing method
CN113197969A (en) * 2021-05-31 2021-08-03 北京洪山医药科技有限公司 Tumor inhibition preparation and preparation method thereof

Similar Documents

Publication Publication Date Title
CN100356972C (en) Chinese medicine for treating amblyopia and myopia
CN107303384A (en) It is a kind of to have medicable Chinese medicine composition and its derivative and product to a variety of symptoms
CN102845745A (en) Dendrobium officinale health-care product
CN101327307A (en) Medicament for treating cancer and preparation method
CN1131053C (en) Chinese medicine for treating diabetes
CN1328834A (en) Capsule for curing cholecystitis
CN103550506B (en) A kind of in radiotherapy with the use of Chinese medicine composition
CN1270047A (en) A tonic tea product and its preparation method
CN102205059A (en) Chinese herbal medicine composition for treating liver cancer, stomach cancer, lung cancer and leukemia and preparation method thereof
CN1186687A (en) Cancer preventing curing medicine series and its preparation
CN109939191A (en) Chinese medicine composition, preparation method and the application of bone marrow suppression after a kind of antagonism chemotherapy of tumors
CN101190306B (en) Compound composition with qi-complementing and spleen-invigorating function and preparation method and application thereof
CN1206612A (en) Anti-cancer health care tea and preparation process thereof
CN105641419A (en) Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer
CN112891485B (en) Traditional Chinese medicine composition for treating neocoronary pneumonia
CN1058911A (en) The compound method of capsule for curing tumour
CN1108554A (en) A series of Chinese medicinal compositions for treating liver cancer, and preparation method thereof
CN1305519C (en) Traditional Chinese medicine prescription for making user being younger
CN100346706C (en) Chinese medicine Zang-fu nursing tea
CN1030166C (en) Method for prodn. of external-use medicinal bag for prevention and treatment of cancer
CN115531488B (en) Composition for soothing liver and strengthening spleen and being used for postoperative adjuvant therapy of breast cancer and preparation method thereof
CN1524550A (en) Traditional Chinese medicine for treating pancreatitis
CN1337251A (en) Anticancer capsule
CN101288683A (en) Application of roselle for preparing health product for promoting lead-eliminating effect
CN106362035A (en) Medicine for treating postpartum sweating disease

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication